close
close

Life expectancy: EPS estimated at 0.07 $

Life expectancy: EPS estimated at 0.07 $

Investing.com – Lifevantage (NASDAQ: ) reported EPS of $0.140 four years ago, $0.07 worse than analyst estimates of $0.210.

If the last four years believed they were worth $48.9 million, the debt service would be worth $51 million.

Forecasts

I have a life expectancy in 2025 with an EPS of $0.700-$0.800. Analysts have an opinion on a revenue of $0.700.

The allocation estimates Lifevantage in business year 2025 at $200,000-$210,000M. Experts have made money with a revenue of $205.8 billion.

The Lifevantage Action has put the official Trading at the Closing Level of 8.81$. In the last 3 months the Performance was plus 15.770%, in the last 12 months at plus 45.910%.

Lifevantage has maintained positive EPS revisions and negative EPS revisions in the last 90 days. The reactions to Lifevantage’s Aktienkurses on the Vorlage of the Geschäftszahlen can be a fact here.

InvestingPro offers life financing based on the Grundlage that uses financial knowledge as “gut”.

Information about life experience you can find here.

All balance dates and results can be found in our balance calendar, for a large number of companies in a real-time activated world.